NinePoint raises $33M for gastrointestinal cancer diagnostic tool

10/14/2010 | (Boston)

NinePoint Medical has obtained $33 million in a round of Series A financing led by Third Rock Ventures. The company will use the proceeds to develop an in vivo pathology system that is designed to help physicians detect and treat tumors in the gastrointestinal tract during biopsies and other procedures.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT